These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Technology assessment and cost-effectiveness analysis: misguided guidelines? Naylor CD; Williams JI; Basinski A; Goel V CMAJ; 1993 Mar; 148(6):921-4. PubMed ID: 8448706 [No Abstract] [Full Text] [Related]
4. Clinical outcome end points and assessment of mechanical ventilation innovations. Dellinger RP Respir Care; 1995 Sep; 40(9):975-9. PubMed ID: 10152243 [No Abstract] [Full Text] [Related]
5. Ultrasound technology: the RADIUS (Routine Antenatal Diagnostic Imaging with Ultrasound) study & national policy. Huang L J Clin Eng; 1994; 19(4):297-309. PubMed ID: 10137111 [TBL] [Abstract][Full Text] [Related]
6. Medical evidence quality: a cause for uncertainty. Part II. Billings J Bus Health; 1988 Jan; 5(3):28-33. PubMed ID: 10302129 [No Abstract] [Full Text] [Related]
7. [Pragmatic randomized controlled trials as a source of data in the assessment of effectiveness of medical technology]. Kaczyński L; Solnica B Przegl Lek; 2012; 69(9):703-7. PubMed ID: 23401993 [TBL] [Abstract][Full Text] [Related]
8. A primer on the assessment of medical technologies. Matuszewski KA Pharm Pract Manag Q; 1997 Jan; 16(4):53-65. PubMed ID: 10164160 [TBL] [Abstract][Full Text] [Related]
9. Ethics, statistics, and technology assessment: the use of a stopping rule and an independent policy and data monitoring board in a cohort study of perioperative cardiac morbidity. The Study of Perioperative Ischemia Research Group. Browner WS Clin Res; 1991 Feb; 39(1):7-12. PubMed ID: 1999083 [No Abstract] [Full Text] [Related]
10. Transmyocardial revascularization for the treatment of coronary artery disease. Tecnologica MAP Suppl; 1999 Jan; ():20-3. PubMed ID: 10346746 [No Abstract] [Full Text] [Related]
11. Jumping in before the water is hot: the need to support randomized controlled clinical trials. Epstein AE J Cardiovasc Electrophysiol; 2004 Aug; 15(8):867-9. PubMed ID: 15333076 [No Abstract] [Full Text] [Related]
12. Medical technology assessment of the ethical, social, and legal implications of pharmacogenomics. A research proposal for an Internet citizen jury. Møldrup C Int J Technol Assess Health Care; 2002; 18(3):728-32. PubMed ID: 12391963 [No Abstract] [Full Text] [Related]
13. Health technology assessment for medical devices in Europe. What must be considered. Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW; Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness/efficacy difference too often ignored. Silverman E Manag Care; 2013 Jan; 22(1):36. PubMed ID: 23373138 [No Abstract] [Full Text] [Related]
16. [One per cent medicine--a source of overtreatment]. Følling I Tidsskr Nor Laegeforen; 2008 Jan; 128(3):334-6. PubMed ID: 18264162 [No Abstract] [Full Text] [Related]
17. Alternative perspectives on the biased foundations of medical technology assessment. Diamond GA; Denton TA Ann Intern Med; 1993 Mar; 118(6):455-64. PubMed ID: 8439120 [TBL] [Abstract][Full Text] [Related]
18. Clinical trials of cost effectiveness in technology evaluation. Valk PE Q J Nucl Med; 2000 Jun; 44(2):197-203. PubMed ID: 10967629 [TBL] [Abstract][Full Text] [Related]
19. The role of randomized trials in the investigation of rapidly evolving technologies. Abel DB; Eikelboom BC; Fogarty TJ; Strandness DE J Endovasc Surg; 1996 May; 3(2):228-30. PubMed ID: 8798142 [No Abstract] [Full Text] [Related]